Seamguard Staple Line Reinforcement
Payments companies reported to CMS as associated with Seamguard Staple Line Reinforcement. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Seamguard Staple Line Reinforcement, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Seamguard Staple Line Reinforcement
These are the largest totals companies reported as associated with Seamguard Staple Line Reinforcement. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaime Ponce-Portugal | Chattanooga, TN | Surgery | $26,849.62 |
| Erik Wilson | Bellaire, TX | Surgery | $22,137.65 |
| Carlos Galvani | New Orleans, LA | Surgery | $19,175.00 |
| Farah Husain | Portland, OR | Surgery | $17,716.59 |
| Brant Heniford | Charlotte, NC | Surgery | $16,815.00 |
| Vivek Prachand | Chicago, IL | Surgery | $16,669.76 |
| William Cobb | Greenville, SC | Surgery | $15,672.74 |
| John Scott | Greenville, SC | Surgery | $15,628.20 |
| Matthew Goldblatt | Milwaukee, WI | Surgery | $15,340.00 |
| John Fischer | Philadelphia, PA | Plastic Surgery | $15,160.07 |
Prescribed Seamguard Staple Line Reinforcement?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.